148 related articles for article (PubMed ID: 31028218)
21. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
[TBL] [Abstract][Full Text] [Related]
22. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors.
Shioyama Y; Nakamura K; Ohga S; Nomoto S; Sasaki T; Yamaguchi T; Toba T; Yoshitake T; Terashima H; Honda H
Jpn J Clin Oncol; 2007 Dec; 37(12):918-23. PubMed ID: 18211982
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].
Hu MM; Yuan QQ; Zhang XS; Yang S; Wang X; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Xu YG; Hao CL; Zhou ZG; Qie S; Lu N; Pang QS; Zhao YD; Sun XC; Li GF; Li L; Qiao XY; Liu ML; Wang YD; Li C; Zhu SC; Han C; Zhang KX; Xiao ZF
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):676-681. PubMed ID: 32867461
[No Abstract] [Full Text] [Related]
24. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
Kawaguchi Y; Nishiyama K; Miyagi K; Suzuki O; Ito Y; Nakamura S
Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
[TBL] [Abstract][Full Text] [Related]
25. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
Wang Q; Yu S; Xiao Z; Liu X; Zhang W; Zhang X; He J; Sun K; Xu T; Feng Q; Zhou Z; Wang L; Yin W
Radiat Oncol; 2015 Jul; 10():142. PubMed ID: 26159510
[TBL] [Abstract][Full Text] [Related]
26. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
[TBL] [Abstract][Full Text] [Related]
27. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
[TBL] [Abstract][Full Text] [Related]
28. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y
Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561
[TBL] [Abstract][Full Text] [Related]
29. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
31. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer.
Jiang W; Sun X; Zhou B; Han C; Liu F; Zheng J; Sun X
J Cancer Res Ther; 2019; 15(4):849-856. PubMed ID: 31436242
[TBL] [Abstract][Full Text] [Related]
33. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
Su J; Zhu S; Liu Z; Zhao Y; Song C
Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
[TBL] [Abstract][Full Text] [Related]
34. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.
Kupelian PA; Buchsbaum JC; Patel C; Elshaikh M; Reddy CA; Zippe C; Klein EA
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):704-11. PubMed ID: 11849793
[TBL] [Abstract][Full Text] [Related]
35. Treatment results of radiotherapy for carcinoma of the cervical esophagus.
Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
Acta Oncol; 2006; 45(8):1120-5. PubMed ID: 17118849
[TBL] [Abstract][Full Text] [Related]
36. A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Gao LR; Wang X; Han W; Deng W; Li C; Wang X; Zhao Y; Ni W; Chang X; Zhou Z; Deng L; Wang W; Liu W; Liang J; Zhang T; Bi N; Wang J; Zhai Y; Feng Q; Lv J; Li L; Xiao Z
BMC Cancer; 2020 Sep; 20(1):901. PubMed ID: 32962674
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience.
Sasaki T; Nakamura K; Shioyama Y; Toh Y; Okamura K; Ohura H; Hirata H; Honda H
Am J Clin Oncol; 2007 Oct; 30(5):514-9. PubMed ID: 17921713
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study.
Yamashita H; Takenaka R; Okuma K; Ootomo K; Nakagawa K
Thorac Cancer; 2016 Sep; 7(5):564-569. PubMed ID: 27766787
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity.
Ristau J; Thiel M; Katayama S; Schlampp I; Lang K; Häfner MF; Herfarth K; Debus J; Koerber SA
Radiat Oncol; 2021 Feb; 16(1):23. PubMed ID: 33522923
[TBL] [Abstract][Full Text] [Related]
40. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
